Dublin, June 21, 2024 (GLOBE NEWSWIRE) -- The "Global Disulfiram Market by Indication (Alcoholism Treatment, Co-occurring Disorders), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) - Forecast 2024-2030" report has been added to ResearchAndMarkets.com's offering.
The Disulfiram Market was estimated at USD 375.19 million in 2023, USD 392.75 million in 2024, and is expected to grow at a CAGR of 4.81% to reach USD 521.63 million by 2030.
The increasing prevalence of alcohol dependency worldwide is a significant factor contributing to the expansion of disulfiram use. Additionally, healthcare providers often support the use of disulfiram for patients struggling with alcoholism, particularly when combined with counseling and psychological support, thereby promoting its adoption. However, certain side effects from the medication itself, including liver toxicity and allergic reactions hamper the market growth. Rising research & development activities to develop more patient-friendly formulations with fewer side effects are expected to create opportunities for market growth.
Regional Insights
In the Americas, the disulfiram market is rapidly expanding due to established healthcare infrastructure and awareness regarding alcohol dependency treatments. The availability of disulfiram is supported by both insurance coverage and treatment programs that incorporate the drug as part of wider alcohol abuse rehabilitation protocols. In South America, the market dynamics differ, with variable access to disulfiram largely influenced by local healthcare policies and economic conditions.
The Asia-Pacific region shows a varied landscape for disulfiram. Countries including Australia and Japan have better access to treatment options, including disulfiram, with supportive healthcare systems and regulations. Europe constitutes a major part of the disulfiram market in the EMEA region. Northern and Western European countries generally display higher awareness and treatment rates for alcoholism, including the use of disulfiram. The regulatory environment and healthcare networks in Europe significantly support the accessibility of disulfiram. Cultural attitudes towards alcohol and alcoholism treatment are expanding the adoption of treatments including disulfiram in the Middle East and Africa.
Market Drivers
- Growing cases of alcohol addiction across the globe
- Increasing patient awareness and higher treatment-seeking rate
Market Restraints
- Side effects associated with the use of disulfiram
Market Opportunities
- Favorable efforts from the governments to curb the use of alcohol
- Innovations in drug delivery systems, such as more efficient oral formulations
Market Challenges
- Issues associated with the effectiveness of disulfiram
Market Segmentation Analysis
- Indication: Rising usage of disulfiram for the treatment of chronic alcoholism
- Distribution Channel: Rising availability of disulfiram in hospital pharmacies which are located within medical facilities
Industry Insights
- Market Disruption Analysis
- Porter's Five Forces Analysis
- Value Chain & Critical Path Analysis
- Pricing Analysis
- Technology Analysis
- Patent Analysis
- Trade Analysis
- Regulatory Framework Analysis
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Disulfiram Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Disulfiram Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Disulfiram Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Disulfiram Market, highlighting leading vendors and their innovative profiles. These include:
- Abbott Laboratories
- Alkem Laboratories Ltd.
- Allergan plc
- Aspen Pharmacare Holdings Limited
- Aurobindo Pharma Limited
- Bausch Health Companies Inc.
- Bayer AG
- Cipla Inc.
- Dr. Reddy's Laboratories Ltd.
- Eli Lilly and Company
- Lupin Pharmaceuticals, Inc.
- Merck KGaA
- Mylan N.V.
- Novartis AG
- Odyssey pharmaceuticals inc
- Par pharmaceutical inc
- Pfizer Inc.
- Sanofi S.A.
- Sun Pharmaceutical Industries Ltd.
- Torrent Pharmaceuticals Ltd.
- Watson laboratories Inc.
- Zydus Lifesciences Limited
Market Segmentation & Coverage
This research report categorizes the Disulfiram Market to forecast the revenues and analyze trends in each of the following sub-markets:
Indication
- Alcoholism Treatment
- Co-occurring Disorders
Distribution Channel
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Region
- Americas
- Asia-Pacific
- Europe, Middle East & Africa
Key Attributes
| Report Attribute | Details |
| No. of Pages | 199 |
| Forecast Period | 2024-2030 |
| Estimated Market Value (USD) in 2024 | $392.75 Million |
| Forecasted Market Value (USD) by 2030 | $521.63 Million |
| Compound Annual Growth Rate | 4.8% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/u7lujt
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
